U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07046988) titled 'Population Pharmacokinetics of Terbinafine in Children With Tinea Capitis' on June 23.
Brief Summary: The goal of this observational study is to characterize the population pharmacokinetics (PPK) of terbinafine in pediatric patients with tinea capitis, evaluate its efficacy and safety, and identify covariates affecting drug disposition in Chinese children aged 2-18 years diagnosed with tinea capitis and treated with oral terbinafine. The main questions it aims to answer are:
What are the terbinafine pharmacokinetic parameters (e.g., AUC, CL, V) in children with tinea capitis, and how do they differ from adult values? Which covariate...